Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02263014 · ClinicalTrials.gov registry record

Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)

A clinical trial of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
345
Enrollment target
2
Study locations

NCT02263014: Active study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

NCT02263014 is a study of Breast Cancer that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 345 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02263014, a study of Breast Cancer, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
345 participants
Enrollment target
2
Study locations

Study Summary

The goal of this research study is to learn more about how different treatment decisions may influence the quality of life in women with breast cancer. Researchers want to use what is learned from this study to help future patients with breast cancer to be more informed when making treatment decisions.

Conditions Studied

Interventions

  • BEHAVIORAL Questionnaires

Study Locations (2)

Texas

  • Kelsey-Seybold - Houston
  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 345 participants
Start Date 2014-02-24
Est. Completion 2028-04-30

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT02263014

The ClinicalTrials.gov registry entry for NCT02263014 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 345 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (88% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.

NCT02263014 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02263014 about?

NCT02263014 is a clinical study titled "Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)". The goal of this research study is to learn more about how different treatment decisions may influence the quality of life in women with breast cancer. Researchers want to use what is learned from this study to help future patients with breast cancer to be more informed when making treatment decisio...

What is the current status of trial NCT02263014?

This trial is currently active not recruiting. The enrollment target is 345 participants. The study started on 2014-02-24. Estimated completion is 2028-04-30.

What conditions does trial NCT02263014 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02263014?

The interventions under investigation include: Questionnaires (BEHAVIORAL).

Who is sponsoring clinical trial NCT02263014?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02263014 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.